8 juin 2020
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ccell.2020.04.018
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32454025
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1878-3686
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B286806D46530
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
S.M. Rubinstein et al., « The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer. », Serveur académique Lausannois, ID : 10.1016/j.ccell.2020.04.018
National and international consortia will play a key role in understanding the effects of the coronavirus disease 2019 (COVID-19) pandemic on cancer patients. The COVID-19 and Cancer Consortium (CCC19) aims to collect and analyze observational data at scale to inform clinical practice in real-time.